Exscientia plc

Artificial intelligence-focused biotech Isomorphic Labs is getting another big infusion of funding to further develop its drug-design system and also to advance some of its programs into the clinic, o

Najat Khan has built her career at the intersection of drug development and technological innovation. As chief R&D and commercial officer at Recursion, she is helping to scale one of biotech’s (or

Pharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh

In the rapidly evolving landscape of pharmaceutical innovation, CHARM Therapeutics stands out as a pioneer in leveraging artificial intelligence (AI) to transform drug discovery. Founded by Laksh Aith